TABLE 3.
Serum | Vancomycin concn (mg/liter) | Binding rate (% ± 1 SD) for vancomycin product: |
|||||
---|---|---|---|---|---|---|---|
A | B | C | D | E | F | ||
Mouse | 1 | 43.1 ± 9.9 | 46.8 ± 4.3 | 43.0 ± 8.3 | 44.7 ± 4.4 | 40.9 ± 3.7 | 40.6 ± 6.5 |
60 | 43.6 ± 6.9 | 44.0 ± 5.5 | 47.9 ± 2.8 | 35.7 ± 4.2 | 46.9 ± 3.2 | 43.1 ± 3.4 | |
300 | 47.5 ± 11.0 | 40.3 ± 13.4 | 50.9 ± 5.7 | 45.1 ± 4.5 | 48.4 ± 4.0 | 45.9 ± 5.6 | |
Mean binding rate | 44.7 ± 9.3 | 43.7 ± 7.7 | 47.3 ± 5.6 | 41.8 ± 4.4 | 45.4 ± 3.7 | 43.2 ± 5.2 | |
Human | 1 | 40.1 ± 6.4 | 35.6 ± 9.2 | 42.4 ± 3.1 | 37.4 ± 8.7 | 33.1 ± 6.1 | 35.1 ± 5.7 |
60 | 41.3 ± 7.1 | 37.0 ± 1.6 | 35.6 ± 4.2 | 33.3 ± 4.4 | 35.7 ± 2.8 | 32.2 ± 5.5 | |
300 | 27.9 ± 6.2 | 33.3 ± 8.4 | 32.4 ± 4.8 | 30.7 ± 8.1 | 34.6 ± 2.6 | 42.9 ± 5.5 | |
Mean binding rate | 36.4 ± 6.5 | 35.3 ± 6.4 | 36.8 ± 4.1 | 33.8 ± 7.1 | 34.5 ± 3.9 | 36.7 ± 5.6 |
The protein binding experiments were conducted in duplicate on two separate days (four samples for each vancomycin product and dose).